Search Orphan Drug Designations and Approvals
-
Generic Name: | Ciclopirox |
---|---|
Date Designated: | 04/17/2018 |
Orphan Designation: | Treatment of congenital erythropoietic porphyria |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Atlas Molecular Pharma S.L. Parque Tecnológico de Bizkaia Building 800 Derio Spain The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-